Table 1 Baseline clinical characteristics of patients with leprosy reactions and controls without reaction
From: Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report
Characteristics | T1R1 | Controls2 | T2R3 | Controls4 |
|---|---|---|---|---|
Patients n (%) | 10 | 10 | 10 | 9 |
Sex | Â | Â | Â | Â |
   men | 8 (80.0) | 8 (80.0) | 8 (80.0) | 7 (77.8) |
   women | 2 (20.0) | 2 (20.0) | 2 (20.0) | 2 (20.0) |
Age (median) | 42.9 | 41.4 | 38.9 | 43.3 |
   (min-max) | (26–60) | (26–59) | (17–69) | (13–68) |
Classification | Â | Â | Â | Â |
   BT | 10 | 10 | - | - |
   LL | - | - | 10 | 9 |
Baciloscopic Index | Â | Â | Â | Â |
   (median) | 0 | 0 | 3.25 | 2.75 |
   (min-max) | (-) | (-) | (2.5–5.0) | (2.5–5.0) |
Reaction at diagnosis | 10 (100.0) | - | 04 (40.0) | - |
Duration of symptoms prior to diagnosis (days) | Â | Â | Â | Â |
   (median) | 50 | - | 15 | - |
   (min-max) | (3–120) |  | (3–60) |  |